Anti-IL26/ AK155/ IL-26 functional antibody

Anti-IL26/ AK155/ IL-26 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL26/IL26 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1025-Ab-1/ GM-Tg-hg-SE1025-Ab-2Anti-Human IL26 monoclonal antibodyHuman
GM-Tg-rg-SE1025-Ab-1/ GM-Tg-rg-SE1025-Ab-2Anti-Rat IL26 monoclonal antibodyRat
GM-Tg-mg-SE1025-Ab-1/ GM-Tg-mg-SE1025-Ab-2Anti-Mouse IL26 monoclonal antibodyMouse
GM-Tg-cynog-SE1025-Ab-1/ GM-Tg-cynog-SE1025-Ab-2Anti-Cynomolgus/ Rhesus macaque IL26 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1025-Ab-1/ GM-Tg-felg-SE1025-Ab-2Anti-Feline IL26 monoclonal antibodyFeline
GM-Tg-cang-SE1025-Ab-1/ GM-Tg-cang-SE1025-Ab-2Anti-Canine IL26 monoclonal antibodyCanine
GM-Tg-bovg-SE1025-Ab-1/ GM-Tg-bovg-SE1025-Ab-2Anti-Bovine IL26 monoclonal antibodyBovine
GM-Tg-equg-SE1025-Ab-1/ GM-Tg-equg-SE1025-Ab-2Anti-Equine IL26 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1025-Ab-1/ GM-Tg-hg-SE1025-Ab-2; GM-Tg-rg-SE1025-Ab-1/ GM-Tg-rg-SE1025-Ab-2;
GM-Tg-mg-SE1025-Ab-1/ GM-Tg-mg-SE1025-Ab-2; GM-Tg-cynog-SE1025-Ab-1/ GM-Tg-cynog-SE1025-Ab-2;
GM-Tg-felg-SE1025-Ab-1/ GM-Tg-felg-SE1025-Ab-2; GM-Tg-cang-SE1025-Ab-1/ GM-Tg-cang-SE1025-Ab-2;
GM-Tg-bovg-SE1025-Ab-1/ GM-Tg-bovg-SE1025-Ab-2; GM-Tg-equg-SE1025-Ab-1/ GM-Tg-equg-SE1025-Ab-2
Products NameAnti-IL26 monoclonal antibody
Formatmab
Target NameIL26
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL26 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1025-Ag-1Recombinant multi-species IL26/ AK155/ IL-26 protein
    CytokineGM-Tg-g-SE1025-Ag-1interleukin 26 (IL26) protein


    Target information

    Target IDGM-SE1025
    Target NameIL26
    Gene ID55801,718027,608923,101094939,782075,100629204
    Gene Symbol and SynonymsAK155,IL-26,IL26
    Uniprot AccessionQ9NPH9
    Uniprot Entry NameIL26_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000111536
    Target ClassificationN/A

    The target: IL26, gene name: IL26, also named as AK155, IL-26. This gene was identified by its overexpression specifically in herpesvirus samimiri-transformed T cells. The encoded protein is a member of the IL10 family of cytokines. It is a secreted protein and may function as a homodimer. This protein is thought to contribute to the transformed phenotype of T cells after infection by herpesvirus samimiri. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.